key: cord-0795430-tx05fxyp authors: Goff, Rebecca R.; Wilk, Amber R.; Toll, Alice E.; McBride, Maureen A.; Klassen, David K. title: Navigating the COVID‐19 pandemic: Initial impacts and responses of the Organ Procurement and Transplantation Network in the United States date: 2020-12-16 journal: Am J Transplant DOI: 10.1111/ajt.16411 sha: e647d2fedb49e512d9d9f6e38388678761ca1caf doc_id: 795430 cord_uid: tx05fxyp COVID‐19 has been sweeping the globe, hitting the United States particularly hard with a state of emergency declared on March 13, 2020. Transplant hospitals have taken various precautions to protect patients from potential exposure. OPTN donor, candidate, and transplant data were analyzed from May 1, 2020 to May 9, 2020. The number of new waiting list registrations decreased, with the Northeast seeing over a 50% decrease from the week of 3/8 versus the week of 4/5. The national transplant system saw near cessation of living donor transplantation (−90%) from the week of 3/8 to the week of 4/5. Similarly, deceased donor kidney transplant volume dropped from 367 to 202 (−45%), and other organs saw similar decreases: lung (−70%), heart (−43%), and liver (−37%). Deceased donors recovered dropped from 260 to 163 (−45%) from 3/8 compared to 4/5, including a 67% decrease for lungs recovered. The magnitude of this decrease varied by geographic area, with the largest percent change (−67%) in the Northeast. Despite the pandemic, discard rates across organ has remained stable. Although the COVID‐19 pandemic continues to evolve, OPTN data show recent evidence of stabilization, an indication that an early recovery of the number of living and deceased donors and transplants has ensued. public health measures such as social distancing and closure of non-essential businesses, the rates of COVID-19 in the US continued at a pace above other countries. 3 Centers for Disease Control (CDC) data showed that the US (and territories) currently lead the world in the number of confirmed cases at over 6.6 million from January 21 to September 17, 2020, 4 with three states reporting over 600,000 cases and five reporting over 200,000. The longterm impacts of COVID-19 on the healthcare system, and more specifically on the transplant system in the United States, remain unknown, but the initial impact on solid organ transplantation was dramatic. The risks of disease transmission through solid organ transplantation and the implications for transplant recipients, transplant center staff, and Organ Procurement Organization (OPO) staff are unknown. 5 Recent publications detail potential impacts to donor organs, including kidney, liver, and heart, though sample sizes are small, data are limited, and not all reports have undergone peer review. [6] [7] [8] [9] [10] [11] Given the respiratory nature of COVID-19, there are obvious impacts to the lungs. As suggested by Michaels 5, 12 An article detailing the Italian experience regarding COVID-19 and transplant described the preventative measures, including infection control and hygiene, limiting surgical activities, and screening/isolation that were implemented in an attempt to ensure safe practice. 13 Kumar Qualitative data continue to be shared worldwide regarding the impact to transplantation from COVID-19 20 ; reports described decreased transplant volumes, complete suspension of live donation in some centers, approaches to donor testing, and modified recipient follow-up through tools such as telehealth. 21, 22 Studies from France and Spain showed profound decreases in deceased donor transplantation. 23, 24 In the United States, Boyarsky et al. and Cholankeril et al. showed a major decrease in waiting list registrations and an increase in waitlist mortality, specifically for kidney transplantation. 25, 26 In March 2020, the Centers for Medicare and Medicaid issued guidance recommending that transplantation surgeries, classified as Tier 3b procedures, should not be postponed, if possible. 27 This allowed the transplant community to make decisions on a candidate-by-candidate basis to reduce the risk to transplant candidates, living donors, recipients, and care providers while continuing, when possible, to provide essential transplant services. This report describes the initial impacts of the pandemic on the transplant system, including deceased and living donation as well as transplant candidates and recipients, in the United States and the responses of the OPTN to mitigate adverse outcomes. This study used data from the OPTN. The OPTN data system in- rebound the next week ( Figure 11 ). Kidney, liver, heart, and lung all saw minimal changes in the discard rate from the earlier to the later time period as shown in Table 2 . There remains concern within the larger healthcare system, and in the transplant community, of adverse impacts of a continued pandemic and subsequent waves of SARS-CoV-2 infections. A successful response will require anticipatory policy responses Olga Kosachevsky for her assistance with copyediting. The authors of this manuscript have no conflicts of interest to disclose as described by the American Journal of Transplantation. Data sharing is not applicable to this article as no new data were created or analyzed in this study. Rebecca R. Goff https://orcid.org/0000-0002-7807-2077 Amber R. Wilk https://orcid.org/0000-0003-1269-1091 David K. Klassen https://orcid.org/0000-0001-5764-0664 Proclamation on Declaring a National Emergency Concerning the Novel Coronavirus Disease (COVID-19) Outbreak Coronavirus COVID-19 Global Cases by the Center for Systems Science and Engineering Cases in the US Coronavirus disease 2019: Implications of emerging infections for transplantation Human kidney is a target for Novel Severe Acute Respiratory Syndrome Coronavirus 2 infection Cardiac involvement in a patient with Coronavirus Disease 2019 (COVID-19) Perioperative presentation of COVID-19 disease in a liver transplant recipient Should COVID-19 concern nephrologists? Why and to what extent? The emerging impasse of angiotensin blockade Covid-19 and kidney transplantation Management of COVID-19 in patients after liver transplantation: Beijing working party for liver transplantation Organ donation during the coronavirus pandemic: An evolving saga in uncharted waters Coronavirus disease 2019 and transplantation: a view from the inside COVID-19: A global transplant perspective on successfully navigating a pandemic Lest we forget Coronavirus disease 2019: Utilizing an ethical framework for rationing absolutely scarce health-care resources in transplant allocation decisions Clinical best practice advice for hepatology and liver transplant providers during the COVID-19 pandemic: AASLD expert panel consensus statement COVID-19: Thoughts and comments from a tertiary liver Lung transplantation as a therapeutic option in acute respiratory distress syndrome for COVID-19-related pulmonary fibrosis ?mid=16BaG frinm 4pz-D8Lnd CiuoH Dd4bJ Su-T&ll=36.48579 91376 Early Impact of COVID-19 on Transplant Center Practices and Policies in the United States Organ procurement and transplantation during the COVID-19 pandemic. The Lancet COVID-19 in Spain: Transplantation in the Midst of the Pandemic Early national and center-level changes to kidney transplantation in the United States during COVID-19 epidemic Early Impact of COVID-19 on Solid Organ Transplantation in the United States table ?q=Unite d%20Sta tes&g=01000 00US.04000.001&tid=ACSDP 1Y2018.DP05&hideP revie w=false. Accessed October R: A language and environment for statistical computing Austria: R Foundation for Statistical Computing UNOS.Covid-19 and solid organ transplant 2019-nCoV (Coronavirus): Recommendations and Guidance for Organ Donor Testing An initial report from the French SOT COVID Registry suggests high mortality due to Covid-19 in recipients of kidney transplants Impact of the COVID-19 pandemic on commercial airlines in the United States and implications for the kidney transplant community Navigating the COVID-19 pandemic: Initial impacts and responses of the Organ Procurement and Transplantation Network in the United States